BlackRock’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $29.1M | Buy |
|
|||||
|
2025
Q2 | $28.1M | Sell |
|
|||||
|
2025
Q1 | $27.7M | Sell |
|
|||||
|
2024
Q4 | $45M | Buy |
|
|||||
|
2024
Q3 | $39.5M | Sell |
|
|||||
|
2024
Q2 | $32.3M | Buy |
|
|||||
|
2024
Q1 | $87.7M | Sell |
|
|||||
|
2023
Q4 | $242M | Buy |
|
|||||
|
2023
Q3 | $189M | Buy |
|
|||||
|
2023
Q2 | $277M | Buy |
|
|||||
|
2023
Q1 | $234M | Buy |
|
|||||
|
2022
Q4 | $152M | Buy |
|
|||||
|
2022
Q3 | $104M | Sell |
|
|||||
|
2022
Q2 | $81.2M | Buy |
|
|||||
|
2022
Q1 | $151M | Buy |
|
|||||
|
2021
Q4 | $339M | Buy |
|
|||||
|
2021
Q3 | $412M | Sell |
|
|||||
|
2021
Q2 | $566M | Sell |
|
|||||
|
2021
Q1 | $549M | Buy |
|
|||||
|
2020
Q4 | $392M | Buy |
|
|||||
|
2020
Q3 | $142M | Buy |
|
|||||
|
2020
Q2 | $46M | Buy |
|
|||||
|
2020
Q1 | $39.3M | Buy |
|
|||||
|
2019
Q4 | $61.9M | Buy |
|
|||||
|
2019
Q3 | $61.1M | Buy |
|
|||||
|
2019
Q2 | $70.8M | Buy |
|
|||||
|
2019
Q1 | $80.5M | Sell |
|
|||||
|
2018
Q4 | $83.3M | Buy |
|
|||||
|
2018
Q3 | $54M | Buy |
|
|||||
|
2018
Q2 | $34.2M | Buy |
|
|||||
|
2018
Q1 | $18M | Buy |
|
|||||
|
2017
Q4 | $21.5M | Sell |
|
|||||
|
2017
Q3 | $49.2M | Buy |
|
|||||
|
2017
Q2 | $27.3M | Sell |
|
|||||
|
2017
Q1 | $41.4M | Buy |
|
|||||
|
2016
Q4 | $553K | Sell |
|
|||||
|
2016
Q3 | $1.31M | Buy |
|
|||||
|
2016
Q2 | $946K | Sell |
|
|||||
|
2016
Q1 | $1.38M | Buy |
|
|||||
|
2015
Q4 | $1.91M | Sell |
|
|||||
|
2015
Q3 | $576K | Buy |
|
|||||
|
2015
Q2 | $486K | Buy |
|
|||||
|
2015
Q1 | $8K | Hold |
|
|||||
|
2014
Q4 | $11K | Hold |
|
|||||
|
2014
Q3 | $7K | Hold |
|
|||||
|
2014
Q2 | $9K | Hold |
|
|||||
|
2014
Q1 | $8K | Buy |
|
|||||
|
2013
Q4 | $6K | Hold |
|
|||||
|
2013
Q3 | $6K | Buy |
|